Isabelle Lee
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research, Multiple Myeloma Research and Treatments, Cell Adhesion Molecules Research, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer(2011)249 cited
- → Abstract 3629: BLZ945, a selective c-fms (CSF-1R) kinase inhibitor for the suppression of tumor-induced osteolytic lesions in bone(2010)9 cited
- → CHIR258: A Multitargeted Growth Factor Receptor Tyrosine Kinase (RTK) Inhibitor Induces Significant Apoptosis of Human FLT3 ITD Acute Myelogenous Leukemia Cells In Vitro and in Vivo.(2004)
- Pre-clinical studies of CHIR258, a small molecule inhibitor that targets FGFR3, for the treatment of t(4;14) multiple myeloma(2004)